Neurology disease summaries Flashcards
Stroke
Rapidly developing clinical symptoms and/or signs of focal, and at times global, loss of brain function, with symptoms lasting more than 24 hours or leading to death with no apparent cause other than that of vascular origin
CVA types
Infraction/Ischaemia
- thrombus formation or embolus (cardioembolic/thromboembolic)
- atherosclerosis
- shock
- vasculitis
Intracranial haemorrhage
CVA risk factors
CVD: angina, MI or PVD Previous stroke or TIA Atrial fibrillation Carotid artery disease Atheroma Hypertension Diabetes and Smoking Vasculitis Thrombophilia Combined contraceptive pill Age > 70 years/Male
stroke symptoms
- Sudden weakness of limbs: initially flaccid and then spastic (UMN)
- Sudden facial weakness
- Sudden onset dysphasia (speech disturbance)
- Sudden onset visual or sensory loss e.g. homonymous hemianopia
TACS
- Unilateral weakness (and sensory deficit) of face, arm and leg
- Homonymous hemianopia
- Higher cerebral dysfunction e.g. dysphasia, visuospatial disorders)
Emboli
PACS
Two of the following:
- Unilateral weakness (and sensory deficit) of face, arm and leg
- Homonymous hemianopia
- Higher cerebral dysfunction e.g. dysphasia, visuospatial disorders)
LACS
One:
Pure sensory
Pure motor
sensori-motor
ataxic hemiparesis
POCS
One:
CN palsy and contralateral motor/sensory deficit
bilateral motor/sensory deficit
conjugate eye movements
cerebellar dysfunction e.g. ataxia, nystagmus
isolated homonymous hemianopia or cortical blindness
Stroke management
CT (diffusion weighted MRI - bleed or infarct)
No bleeding - aspirin 300mg STAT and then for 2 weeks
Thrombolysis with alteplase within 4.5 hours
Endarterectomy - within 6 hours
Stroke - secondary management
mild stroke: aspirin 300mg stat, 2 weeks of 300mg) and clopidogrel for up to 3 weeks. Then step down to clopidogrel 75mg OD
Atorvastatin 80mg
If AF
- Heparin
- Intermittent pneumatic compressions
reduce BP gradually
TIA
Defined as transient neurological dysfunction secondary to ischaemia (lack of blood flow) without infarction (death of tissues).
TIA management
- Aspirin 300mg daily
- clopidogrel
- Carotid endarterectomy
Receptive dysphagia
is difficulty in comprehension: Wernickes area (superior temporal)
Expressive dysphagia
difficulty in putting words together to make meaning: Broca Area (frontal)
intracranial bleeds signs/symptoms
Seizures
Focal weakness
Vomiting
Reduced consciousness`
Other sudden onset neurological symptoms
GCS
Eyes Spontaneous = 4 Speech = 3 Pain = 2 None = 1
Verbal response Orientated = 5 Confused conversation = 4 Inappropriate words = 3 Incomprehensible sounds = 2 None = 1
Motor response
Obeys commands = 6
Localises pain = 5
Normal flexion = 4
Abnormal flexion = 3 (Decorticate posturing)
Abnormal Extension = 2 (decerebrate posturing)
None = 1
Decorticate posturing
lateral corticospinal tracts are disrupted so the rubrospinal tracts takes over causing the abnormal flexion to the upper extremities and the reticulospinal tracts takes over causing the extension of the legs.
Decerebrate
Below the red nucleus
In this case, both the lateral cortical spinal tract and rubrospinal tract are damage so the reticulospinal tract takes over and causes extension of the whole body.
Subdural haematoma
collection of blood between the dura and the arachnoid layer, typically caused by a traumatic event.
damages bridging veins (drain cortex and into sinuses)
elderly, alcoholics and epileptics
Acute SDH SIGNS/SYMPTOMS
decreased state of consciousness
Headache
personality change and unsteadiness
Raised ICP, seizures, localising neurological symptoms. unequal pupils, hemiparesis) occur late up to 1 month after injury
SDH diagnosis
CT scan they have a crescent shape and are not limited by the cranial sutures (they can cross over the sutures).
chronic SDH
brain ages - bridging veins are stretched and even minor trauma can rupture. Longer course (3-7 weeks)
leaky vessels result in the accumulation of blood in the subdural space and an osmotic gradient can form which draws more fluid in that space.
chronic SHD signs/symptoms and diagnosis
mean of 3-7 weeks before symptoms starts to present.
The most common presenting complaints are headache and confusion. Other symptoms include: urinary incontinence, weakness, seizures, cognitive dysfunctions and gait abnormalities
hypodense on CT scan
SDH management
prevent secondary insults
- hypoxia, hypotension and mass lesions
- control ICP and CPP
Craniotomy or burr hole washout
Raised ICP medical management and surgical
Sedation: Propofol, benzodiazepines, barbiturates
Maximise venous drainage of brain
- Head of bed tilt: 30 degrees for head position
- Cervical collars, ET tube ties
CO2 control
Osmotic diuretics (Mannitol, Hypertonic saline)
CSF release
surgical: decompressive craniectomy
EDH
rupture of the middle meningeal artery (the anterior branch of the middle meningeal artery is vulnerable to injury as it runs underneath the pterion) in the temporo-parietal region.
associated with a temporal fracture
between skull and dura
EDH signs/symptoms
brief loss of consciousness, followed by a period in which the patient regains consciousness and awareness (called a lucid interval: can be a few hours to a few days)
After that the patients further deteriorates, exhibiting symptoms such as: headache, vomiting, contralateral hemiparesis with brief reflexes
If bleeding continues, the ipsilateral pupillary dilatation (causes the uncus of the temporal lobe to herniate and compress on the pupillary fibres of the oculomotor nerve).
Bilateral weakness develops and breathing becomes deep and irregular (brainstem compression)
Death follows a period of coma
EDH diagnosis
CT scan they have a bi-convex shape and are limited by the cranial sutures
Intracerebral haemorrhage Iv
CT scan: Well demarcated intra-parenchymal haematomas
Intracerebral haemorrhage management
• Surgical evacuation of haematoma +/-treatment of underlying abnormality
Good - if small superficial clot and good neurological status
Poor - if large basal ganglia or thalamic clot with major focal deficit or deep coma
Subarachnoid Haemorrhage
bleeding into the subarachnoid space, where the cerebrospinal fluid is located. Between pia and arachnoid membrane
Usually an aneurysm
Subarachnoid Haemorrhage signs/symptoms
sudden onset occipital headache that occurs during strenuous activity “thunderclap headache”
N&V, neck stiffness and photophobia (meningeal irritation), Kernigs sign, focal neurological changes, 3rd nerve palsy (posterior communicating artery aneurysm)
Subarachnoid Haemorrhage Iv
CT
LP
Angiography (CT or MRI)
Subarachnoid Haemorrhage management
surgical: coiling or clipping
Subarachnoid Haemorrhage complications
vasospasm: prolonged arterial contraction - delayed ischaemic neurological deficit (3-14 days)
- nimodipine
rebleeding
SIADH: hyponatraemia
Hydrocephalus
antiepileptic medications
Arteriovenous malformations
AVM is a complex tangle, or nidus, of arteries and veins connected together with one or more fistulas, creating a shunt (no capillary bed present).
Usually intraparenchymal
Arteriovenous malformations Iv and management
Catheter angiography
If accessible to surgery then an open craniotomy is done with excision of AVM
Stereotactic radiosurgery: if risk of surgery outweighs the benefit. This procedure is accepted for some small AVMs and/or deep AVMs
AVM is in eloquent brain/deep tissue inaccessible to surgery then endovascular coiling can be considered
Cavernous malformation
well circumscribed benign vascular lesions encompassing sinusoidal spaces lined by endothelium and separated by elastin (gross pathology resembles a mulberry), with a rim of hemosiderin-laden macrophages surrounding it.
No intervening brain parenchyma
Cavernous malformation Ix
CT
MRI: popcorn
Dural venous sinus thrombosis - most common
sagittal sinus thrombosis or transverse sinus thrombosis
Cortical sinus thrombosis
Usually occurs with a sinus thrombus as it extends into the cortical veins causing infarction in venous territory.
Multiple sclerosis
Chronic and progressive condition that involves demyelination of the myelinated neurones in the central nervous system.
young adults and women
MS causes
Multiple genes, Epstein–Barr virus (EBV), Low vitamin D, Smoking, obesity, living near the equator
Pyramidal dysfunction
Increased tone
spasticity: velocity dependent increase in tone
- extensors: upper limb
- flexors: lower limb
Weakness:
- upper limbs: flexors strong, extensors weak
- lower limbs: extensors strong, flexors weak
MS signs/symptoms
Pyramidal dysfunction Optic neuritis Sensory symptoms LUTD Cerebellar Fatigue Cognitive impairment
Optic neuritis
demyelination of the optic nerve and unilateral loss of vision
- central scotoma
- pain on eye movement
- impaired colour vision (dyschromatopsia)
- RAPD
MS: Disease patterns
Clinically isolated syndrome
relapsing/remitting
Secondary progressive
Primary progressive
MS Iv
over 1 year
2 episodes suggestive of demyelination and dissemination in time and place
LP: oligoclonal bands in CSF
Acute exacerbation/relapse MS treatment
Mild: symptomatic treatment or observe and it gets better
- amitriptyline or gabapentin for paranaesthesia/neuralgia/neuropathic pain
Moderate – oral steroids e.g. methylprednisolone for 5 days
Severe – admit/IV steroids (1g IV daily for 3-5 days)
Optic neuritis acute management
IV methylprednisolone followed by oral prednisolone
Pyramidal dysfunction management (MS)
- Exercises
- Oral baclofen and Tizanidine
- Benzodiazepine
- B toxin in joints
- intrathecal baclofen/phenol
Sensory symptoms (MS) treatment
Anti-convulsant e.g. gabapentin
Anti-depressant e.g. amitriptyline
Tens machine
Acupuncture
Lignocaine infusion
LUTD management (MS)
Bladder drill (training)
Anti-cholinergic e.g. oxybutynin and tolterodine (worsen cognitive impairment)
Desmopressin e.g. long journey
Catheterisation e.g. significant retention
Disease modifying MS
1st line therapy: relapsing and remitting
- Tecfidera, aubagio
- Interferon Beta – injection (sc/IM):
- Glitiramer Acetate -injection
2nd therapy: RRMS
- Anti CD20 (ocrelizumab, Rituximab)
- Anti CD 50 (Alemtuzemab)
- Anti integrin (Natilizumab)
- Fingolimod, cladrabine
3rd line:
- Mitoxantrone
- HSCT
Motor Neurone disease
Progressive, ultimately fatal condition where the motor neurones stop functioning (motor neuron degeneration/death)
Selective loss of neurons in the motor cortex, cranial nerve nuclei and anterior horn cells
no effect on the sensory neurones or sphincter disturbance and patients should not experience any sensory symptoms.
MND types
- Amylotropic lateral sclerosis: UMN/LMN: Motor cortex and anterior horn cells
- Progressive bulbar palsy: CNIX-XII, UMN/LMN
- Primary lateral sclerosis: UMN - loss of betz cells in motor cortex
- Progressive muscular atrophy - LMN - loss of anterior horn cells
MND signs/symptoms
late middle aged (e.g. 60) man, possibly with an affected relative spastic gait, foot drop +/- proximal myopathy, weak grip and shoulder abduction
LMN signs/symptoms
o Muscle wasting
o Reduced tone
o Fasciculations (twitches in the muscles)
o Reduced reflexes
UMN signs/symptoms
o Increased tone or spasticity o Brisk reflexes/hyperreflexia o Upgoing plantar responses o Spastic gait o Exaggerated jaw jerk o Slowed movements
Bulbar variant (Motor Neurone) management
Communication needs (Speech therapy, technology from tablets to ‘voice banking’, pen and paper when tired)
small high energy supplements
early insertion of gastrostomy tubes (PEG, RIG or NG tube)
sialorrhoea
- hyoscine/buscopan
- Glycopyrronium
- botox
- suction
Riluzole
the progression of the disease and extend survival by a few months in AML. causing lots of liver and kidney problems (needing blood tests) and only gives you 3 months of disabling
inhibitor of glutamate and NMDA receptor antagonist
Parkinson’s Disease
progressive reduction of dopamine in the basal ganglia of the brain, leading to disorders of movement (hypokinetic)
Loss of dopaminergic neurons from the pars compacta region of the substantia nigra and the presence of alpha-synuclein containing inclusions known as Lewy bodies in specific areas of the brain
Parkinson’s Disease risk factors
Age – most important Male sex – slight increase Rural living – slight increase Smoking – decreases risk FH of Parkinson’s disease Drugs - cyclizine or metaproclomide
Parkinson’s Disease signs/symptoms
PD: usually asymmetrical
- Resting tremor (improves with movement)
- Rigidity: Cogwheel
- Bradykinesia (slower movements)
- Postural disturbances
Other signs/symptoms of PD
Depression Sleep disturbance and insomnia (lack of REM sleep?) Loss of the sense of smell (anosmia) Cognitive impairment and memory problems GI dysfunction
PD should not present with
Postural instability leading to falls occurs relatively late in the clinical course of PD (if it is happening early, back to differential diagnosis)
Failure to respond to even large doses of levodopa is usually a strong indicator that the patient does not have idiopathic PD
Early-onset bulbar problems, dementia and hallucinations, preferential involvement of lower limbs
Prominent eye movement disorder (*supranuclear eye palsy)
Intrusive early autonomic problems
PD management
- levodopa: cross BBB
- combined with peripheral decarboxylase inhibitors e.g. carbidopa/co-careldopa
- reserved when other treatments become ineffective and symptoms less controlled - COMT inhibitors e.g. entacapone
- take with levodopa in brain - Dopamine agonist e.g. bromocrytine.
- delay the use of levodopa in early disease and are then used in combination with levodopa to reduce the dose of levodopa
- apomorphine (continuous sc infusion) - Monoamine oxidase-B-inhibitors e.g. selegiline: specific to dopamine, help increase circulating dopamine
- Anticholinergics such as trihexyphenidyl or diphenhydramine (Benadryl) aim to combat tremor, but usually cause severe side effects
PD side effects of medication
- dopamine side effects
- dystonia
- chorea
- athetosis
- Vomiting: doperidone - dopamine agonists
- pulmonary fibrosis
- daytime somnolence & oedema - Impulse control disorders, including pathological gambling, hypersexuality, binge eating, compulsive spending occur much more often with dopamine agonists
- Hallucinations and not prescribed in elderly with CI
Drug induced psychosis PD Mx
clozapine (agranulocytosis) and quetiapine
Vascular Parkinsonism
clinical features of parkinsonism that are presumably caused by cerebrovascular disease
- predominantly lower limbs (lower body parkinsonism)
- rest tremor uncommon
- spasticity, hemiparesis and pseudobulbar palsy
Vascular Park Iv
Poor levodopa response
Structural brain imaging will guide diagnosis
Drug Induced Parkinsonism Mechanism
Medicines: block the action of dopamine, the neurotransmitter that is gradually lost in the brains of people with Parkinson’s. They include: Neuroleptic or antipsychotic drugs used to treat schizophrenia and other psychiatric problems.
Drug Induced parkinsonism signs/symptoms
- Symmetrical
- Postural Tremor e.g. oustretched arms
- Orolingual dyskinesias, tardive dystonia and akathisia
Drug induced parkinsonism mx
remove drug that blocks dopamine
benign essential tremor
AD, fine tremor of voluntary muscles
- Fine tremor (Hands the most however can affect head, jaw and vocal)
- Symmetric, postural or kinetic tremor with higher frequency (up to 12 Hz)
- more prominent on voluntary movement
- Worse when tired, stressed or after caffeine
- Alcohol responsiveness: improved
- Head tremor – if present – mild
- Absent during sleep (no voluntary movements during sleep)
Benign essential tremor mx
to improve symptoms
- propranolol
- Primidone
Multi system atrophy
neurones of multiple systems of nerves in the brain to degenerate including basal ganglia
6th and 7th decade
Multi-system atrophy signs/symptoms
autonomic dysfunction (postural hypotension, constipation, abnormal sweating and sexual dysfunction) and cerebellar dysfunction (ataxia)
core triad: dysautonomia, cerebellar features and parkinsonism
Progressive supranuclear palsy
Symmetric akinetic-rigid syndrome with predominantly axial involvement. PSP occurs when brain cells in certain parts of the brain are damaged as a result of a build-up of a protein called tau.
Primary dementias
AZ, Picks, Lewy body, Huntington’s
Alzheimer disease
Neurodegenerative proteinopathy (amyloid)
usually sporadic
Familial: APP (amyloid precursor), presenilin 1 & 2 and e4
Pathology of AD
Disruption of cholinergic pathways in the brain + synaptic loss: Loss of cortical neurones (decrease in front, temporal and parietal lobe atrophy)
- neurofibrillary tangles (tau)
- senile plaques of amyloid b protein (extracellular)
- both cause excitotoxicity
AD Ix
clinical
MRI: temporal and parietal loss
SPECT: temporoparietal and reduced metabolism
CSF: Reduces amyloid and increase in tau
AD Mx
Cholinesterase inhibitors - rivastigmine, galantamine and donepezil
NMDA receptor blocker e.g. Menantine - protects against too much glutamate
Dementia with lewy bodies
Protein deposits called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control).
Neurodegenerative proteinopathy (a-synuclein)
late onset dementia > 65 years
Leads to disruption of cholinergic (memory problems) and dopaminergic pathways (PD features)
signs/symptoms of lewy body
progressive cognitive decline but is fluctuating cognitive impairment
There are associated symptoms of visual hallucinations (shadow behind them or animals/faces at the window), delusions, disorders of REM sleep and fluctuating consciousness
Motor features of parkinsonisms
Lewy Body Ix and Mx
Dat and alpha synuclein ligand imaging/a-synuclein in CSF
Mx
- small levodopa dose
- trial cholinesterase inhibitors
Parkinsons disease dementia
PDD >1 year of presentation
Huntington’s chorea
AD “trinucleotide repeat disorder” that involves a genetic mutation in the HTT gene on chromosome 4. Production of abnormal glutamine residues (toxic)
Anticipation: earlier age of onset and increased severity
Huntington’s chorea pathology
loss of basal ganglia cells (basal ganglia, cuada and putamen) and cortex (frontal, parietal)
HC signs/symptoms
- 30-50 yrs
- cognitive, psychiatric or mood problems
- development of movement disorders
- Chorea (involuntary, abnormal movements)
- Rigidity and inability to walk
- Bradykinesia
- Eye movement disorders
- dysarthria
- dysphagia
- Myoclonus
- slurred speech, depression , irritability and apathy
- eventual involvement of memory
HD Mx
MDT
Mx for disordered movement
- Antipsychotics (e.g. olanzapine)
- Benzodiazepines (e.g. diazepam)
- Dopamine-depleting agents (e.g. tetrabenazine): Huntington’s: too much dopamine therefore lose it
- Depression can be treated with antidepressants.
Picks
dementia commencing in middle life (usually between 50 and 60 years) characterised by progressive changes in character and social deterioration leading on to impairment of intellect, memory and language
Build up of Tau
Picks signs/symptoms
Personality and behavioural change (apathy [lack of interest], loss of empathy, stereotyped or compulsive behaviours, hyperorality)
Find it very difficult to stop behaviours when they start (compulsive behaviour)
Speech and communication problems
Change in eating habits
Reduced attention span
Picks Ix and Mx
MRI: focal atrophy of frontotemporal lobes
SPECT: frontotemporal reduced metabolism
CSF: increased tau/normal amyloid (not affected in this)
Mx
- Trazadone: anti-depressant/anti-psychotic - slightyl sedative
Vascular dementia
sudden onset and stepwise deterioration
Multi infarct dementia
Disorder involving a deterioration in mental function due to cumulative damage to the brain through hypoxia or anoxia (lack of oxygen) as a result of multiple blood clots within the blood vessels supplying the brain
Successive multiple cerebral infarctions cause increasingly larger areas of cell death and damage
Multi-infarct dementia Ix
aware of it
Abrupt onset
Stepwise progression (further small infarcts occurring)
history of hypertension or stroke
Evidence of stroke will be seen on CT or MRI
Functional Cognitive impairment
everyday forgetfulness
Scores well at congitive tests such as addenbrookes test and still does a hard job
Mx
Exclude a mood disorder (depression can cause deficits in attention, excutive function and memory)
Prion disease
Most common human prion disease = Creutzfeldt-jakob disease
Natually occuring PrPc (everyone has it) – misfolded PrPsc = neurodegeneration
Most concentrated in CNS and lymphatics
Prion disease types
- sporadic
- variant: Bovine spongiform encephalopathy
- iatrogenic
- genetic
Transient global amnesia
- sudden, temporary episode of memory loss that can’t be attributed to a more common neurological condition, such as epilepsy or stroke
- transient changes in the hippocampus in temporal lobe (where memories are stored)
- anterograde > retrograde amnesia
- transient 4-6 hours
Transient epileptic amnesia
Transient epileptic amnesia (TEA) is a rare but probably underdiagnosed neurological condition which manifests as relatively brief and generally recurring episodes of amnesia caused by underlying temporal lobe epilepsy.
Transient epileptic amnesia
complex activities with no recollection events